COMMUNIQUÉS West-GlobeNewswire

Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference
22/09/2026
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend the corporate presentation at https://lythampartners.com/fall2026/ [...]
Novo and UNICEF expand partnership to support a healthier start for more than 80 million children
22/09/2026
The four-year expansion will focus on childhood overweight and obesity prevention for over 80 million children across seven priority countries: Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya Novo [...]
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System
22/09/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgical cases with [...]
SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors
22/09/2026
New director brings nephrology development expertise and over 30 years of experience in the biopharmaceutical industry JERSEY CITY, N.J., Sept. 22, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or [...]
Clene to Present at Upcoming Investor Conferences
22/09/2026
SALT LAKE CITY, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) today announced that management will participate at the 5 th Annual ROTH Healthcare Opportunities Conference and at the Lytham Partners [...]
Envisagenics and Boehringer Ingelheim Enter Multi-Target Collaboration to Develop First-in-Class Precision Therapies Based on RNA Splicing-Derived Targets for Hard-to-Treat Cancers
22/09/2026
Envisagenics’ AI-powered SpliceCore ® platform opens up alternative RNA splicing – one of the last largely untapped sources of tumor-specific targets – for precision oncology Boehringer Ingelheim may apply selected [...]
Adventist Health Bakersfield Introduces Kern County’s First Next Generation Robotic-Assisted Bronchoscopy
22/09/2026
Advanced technology helps physicians detect lung cancer earlier and improve treatment BAKERSFIELD, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Kern County and surrounding areas now have access to a next-generation, [...]
Medera Expands Singapore Presence Through Partnership with National Heart Centre Singapore
22/09/2026
Medera establishes Singapore laboratory and office to support human mini-heart cardiac disease modeling, drug discovery, and regional cardiovascular clinical innovation BOSTON and SINGAPORE, Sept. 22, 2026 (GLOBE [...]
Adagene Announces NMPA Clearance of Investigational New Drug Application for ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager
22/09/2026
Phase 1 study with ADG138 for patients with advanced solid tumors is expected to begin in China in the fourth quarter of 2026 ADG138 is a double-masked T-cell engager, applying Adagene’s proprietary SAFEbody® precision [...]
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
22/09/2026
Patient screening for the Phase 2a study is expected to begin by the first quarter of 2027 Filana has engaged a leading clinical research organization, has identified clinical trial sites, and is recruiting potential [...]
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
22/09/2026
HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company developing multi-antigen recognizing (MAR)-T cell therapies for the treatment of hematologic [...]
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity
22/09/2026
-- First targeted therapy approved in Canada for patients four years and older living with acquired hypothalamic obesity (HO) -- BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a [...]
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
22/09/2026
Nes-Ziona, Israel, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today announced the termination of a [...]
Lymphatic Malformation Alliance (LMA) Meets with FDA Leadership to Elevate Awareness of Lymphatic Malformations and Advance the Urgent Need for Approved Treatments
22/09/2026
LMA brings patient and physician perspectives to FDA leadership to elevate awareness of lymphatic malformations Patient experience highlights the serious, lifelong burden and significant unmet need LMA calls for greater [...]
SafeSpace Global Secures Up to $11 Million in Financing Capacity to Support Next Phase of Growth
22/09/2026
Multi-year financing framework expands access to growth capital and provides increased financial flexibility as SafeSpace Global KNOXVILLE, Tenn., Sept. 22, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: [...]
TETmedical Strengthens Board of Directors with Appointment of Marc Lebel and Patrick McBrayer, Veteran Life Sciences Entrepreneurs and Company Builders
22/09/2026
New Directors Bring Track Record of Founding, Scaling, and Exiting Institutionally-Backed MedTech and Life Sciences Companies as TETmedical Advances Its Pivotal Study FAIR HAVEN, N.J and ITHACA, N.Y., Sept. 22, 2026 ( [...]
SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone
22/09/2026
First patient dosed marks an important step for the SMA community and highlights a growing rare disease manufacturing partnership, with future GEMMABio programs expected to leverage SK pharmteco’s SKyvec™ viral vector [...]
Sightpath Medical Brings Its Expanded Retina Services to AAO 2026
22/09/2026
Booth 1644, Hall E, shared with technology partner IQity, October 10-12 in New Orleans BLOOMINGTON, Minn., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Sightpath Medical, the nation's leading provider of mobile ophthalmic [...]
New Research Provides Groundbreaking Look Into Brain Processes Behind PANS, PANDAS, Sydenham’s Chorea
22/09/2026
Columbia University researchers identify key inflammatory processes affecting blood-brain barrier in study of post-streptococcal encephalitis NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- For far too long, children and [...]

Pages